Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001417010 | SCV001619203 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2024-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001417010 | SCV002812484 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2021-10-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003965778 | SCV004785626 | likely benign | COL12A1-related disorder | 2023-12-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |